Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chris Hudson, PhD
Department of Ophthalmology, Toronto Western Hospital, Toronto
Study Chair - Graham E Trope, MB, FRCSC
University of Toronto, Department of Ophthalmology
Principal Investigator - John Flanagan, PhD
Department of Ophthalmology, Toronto Western Hospital, Toronto
Study Chair - Yvonne M Buys, MD, FRCSC
University of Toronto, Department of Ophthalmology, Toronto Western Hospital, Toronto
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Department of Ophthalmology and Visual Sciences; Toronto Western Hospital
Toronto, Ontario, Canada
Rony Rachmiel, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2005
- Primary completion
- —
- Completion
- 30 Jun 2006
- Last update posted
- 25 Jul 2007
- Registered enrollment
- 17
- Registry id
- NCT00152932
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.